88 coding-"https:"-"FEMTO-ST"-"CSIC" "https:" "https:" "https:" "https:" "https:" "https:" "Dr" "P" positions at Lunds universitet
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
-doctoral positions within in the AMBER co-fund project please visit https://www.euraxess.se/jobs/392999 The interviews will start in April/May 2026. For more information about AMBER, application and
-
-doctoral positions within in the AMBER co-fund project please visit: https://www.euraxess.se/jobs/392999 The interviews will start in April/May 2026. For more information about AMBER, application and
-
execution of experiments, and discuss development of eg. user sample environments or analysis code for nanoprobe experiments As a scientist, you are ready to perform scientific research or nanoprobe method(s
-
position within a Research Infrastructure? No Offer Description The Division of Synchrotron Radiation Research (http://www.sljus.lu.se ) is a part of the Department of Physics and has more than 50 employees
-
in a wide range of biochemical and biophysical methods and offers a creative and strong research environment with excellent infrastructure (see https://www.cmps.lu.se for more information). The
-
of early human development. The group was established in 2022 by Dr Christopher Douse and currently consists of seven researchers. The group works closely with in close alignment with strategic
-
Malmö, is a knowledge-intensive meeting place for students, teachers and researchers from all over the world. Where to apply Website https://lu.varbi.com/en/what:job/jobID:888936/type:job/where:39/apply:1
-
conducted implementations of algorithms and simulations using contemporary GPU hardware, or Profound knowledge and experience of the DUNE software environment (https://dune-project.org/ ) (knowledge and
-
positions within in the AMBER co-fund project please visit https://www.euraxess.se/jobs/392999 . The interviews will start in April/May 2026. For more information about AMBER, application and evaluation
-
targeted and effective therapies can be developed. The project is led by Dr Niklas Landberg in a newly established research group with close collaborations with other research teams at the division and with